These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17389289)

  • 1. Delivery of cancer screening: how important is the preventive health examination?
    Fenton JJ; Cai Y; Weiss NS; Elmore JG; Pardee RE; Reid RJ; Baldwin LM
    Arch Intern Med; 2007 Mar; 167(6):580-5. PubMed ID: 17389289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.
    Ruffin MT; Gorenflo DW; Woodman B
    J Am Board Fam Pract; 2000; 13(1):1-10. PubMed ID: 10682879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
    Ciatto S; Castiglione G
    Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
    Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
    Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer preventive services, socioeconomic status, and the Affordable Care Act.
    Cooper GS; Kou TD; Dor A; Koroukian SM; Schluchter MD
    Cancer; 2017 May; 123(9):1585-1589. PubMed ID: 28067955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age and comorbidity on colorectal cancer screening among older veterans.
    Walter LC; Lindquist K; Nugent S; Schult T; Lee SJ; Casadei MA; Partin MR
    Ann Intern Med; 2009 Apr; 150(7):465-73. PubMed ID: 19349631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening: scientific review.
    Walsh JM; Terdiman JP
    JAMA; 2003 Mar; 289(10):1288-96. PubMed ID: 12633191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.